Some aspects of the use of fosfomycin in the treatment of postcoital cystitis in the practice of a dermatovenerologist

Author: К.О. Bardova, P.L. Shupik National Medical Academy of Postgraduate Education, Kyiv


Cystitis is the most common clinical manifestation of urinary tract infections, accompanied by urinary disorders and pelvic pain. The term «cystitis» is used to describe inflammation in the bladder.

Phosphomycin is the main dgugs for treatment of uncomplicated, including postcoital cystitis, according to the European Guidelines for the Treatment of Urological Infections 2019 (management guideline).

Оbjective

The development of early tacticsof postcoital and non-complicated cystitis.

Materials and methods

Under our observation, there was a group of women with postcoital cystitis in the number of 15 people and 10 women with uncomplicated cystitis of bacterial nature, aged 21 to 48 years, who was on outpatient treatment at the Kyiv City Dermatovenerology Hospital and other clinical bases of the Department of Dermatology.

Results and discussion

Single use of Phosphomed in post-coital and uncomplicated cystitis in women has been shown to have antimicrobial and anti-inflammatory effects, reduce clinical manifestations of the disease, reduce discomfort and significantly improve the quality of life of patients.

Conclusions

The results make it possible to recommend Phosphomed as a drug of choice in patients with postcoital and uncomplicated cystitis, even with single use, and also to prevent recurrence.

Key words: cystitis, postcoital cystitis, urinari’s tract infection, antibacterial drugs, phosphomycin.

ARTICLES FROM CATEGORY
Support of educational events. Participation of World Medicine in the First Congress of Optometrists of Ukraine.
Cetirizine is an effective and safe antihistamine (literature review, results of clinical researches)
All-Ukrainian Scientific and Practical Conference “Aspects of Internal Medicine in Wartime 2024"

PROVE YOU ARE A MEDICAL PROFESSIONAL

Attention: This section is intended for healthcare professionals only. If you are not a medical professional, you can return to the main page by clicking the “No” option

CARD-NOTIFICATION OF AN ADVERSE DRUG REACTION AND/OR LACK OF EFFICACY OF THE MEDICINE

INFORMATION ABOUT THE PATIENT

SUSPECTED AR/LE

Suspected AR (describe each clinical manifestation of the AR with dates and times of onset and end and outcome)/Indication of the LE

INFORMATION ABOUT SUSPECTED MEDICINES

INFORMATION ABOUT RELATED MEDICINES

(with the exception of drugs used to correct the effects of AR/LE)
(concomitant diagnoses, laboratory and instrumental studies, allergy history, pregnancy with gestational age, method of conception, pregnancy outcome (if the pregnancy ended, the date of delivery, type of delivery, etc.)

Information about the messenger

INFORMATION ABOUT THE MEDICAL/PHARMACY SPECIALIST

(if not the notifier)

MESSAGE CARD for the patient

to provide the patient and/or his/her representative with information on adverse drug reactions and/or lack of efficacy of the drug

INFORMATION ABOUT THE PATIENT

Information about the suspected medicine

Information on the prescription of the suspected medicinal product

Information about the messenger

Information about the physician, healthcare facility and place of residence of the patient who had an adverse medicine reaction and/or lack of efficacy of the medicine

розробка сайту Estetic web design